These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 16782220)

  • 21. Proposal to improve vertebrate cell cultures to establish them as substitutes for the regulatory testing of chemicals and effluents using fish.
    Schirmer K
    Toxicology; 2006 Jul; 224(3):163-83. PubMed ID: 16765501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays?
    Seiler A; Oelgeschläger M; Liebsch M; Pirow R; Riebeling C; Tralau T; Luch A
    Arch Toxicol; 2011 Nov; 85(11):1361-72. PubMed ID: 22008952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays.
    Benigni R; Bossa C; Tcheremenskaia O; Giuliani A
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):809-19. PubMed ID: 20438313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment).
    Spielmann H; Grune B; Liebsch M; Seiler A; Vogel R
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):225-33. PubMed ID: 18440212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing and assessment strategies, including alternative and new approaches.
    Meyer O
    Toxicol Lett; 2003 Apr; 140-141():21-30. PubMed ID: 12676447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal testing: more than a cosmetic change.
    Abbott A
    Nature; 2005 Nov; 438(7065):144-6. PubMed ID: 16281001
    [No Abstract]   [Full Text] [Related]  

  • 28. Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.S.
    Becker RA; Borgert CJ; Webb S; Ansell J; Amundson S; Portier CJ; Goldberg A; Bruner LH; Rowan A; Curren RD; Stott WT
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):18-22. PubMed ID: 16876299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The promise of toxicogenomics.
    Waring JF; Halbert DN
    Curr Opin Mol Ther; 2002 Jun; 4(3):229-35. PubMed ID: 12139308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity testing gets a makeover.
    Abbott A
    Nature; 2009 Sep; 461(7261):158. PubMed ID: 19741676
    [No Abstract]   [Full Text] [Related]  

  • 31. EU research activities in alternative testing strategies: current status and future perspectives.
    Vanhaecke T; Snykers S; Rogiers V; Garthoff B; Castell JV; Hengstler JG
    Arch Toxicol; 2009 Dec; 83(12):1037-42. PubMed ID: 19908029
    [No Abstract]   [Full Text] [Related]  

  • 32. Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive.
    Tweats DJ; Scott AD; Westmoreland C; Carmichael PL
    Mutagenesis; 2007 Jan; 22(1):5-13. PubMed ID: 17142828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative methods in toxicology tests: in vitro toxicity.
    Cinelli S; Falezza A; Meli C; Ciliutti P; Vericat JA
    Cytotechnology; 1991; 5 Suppl 1():51-4. PubMed ID: 1367120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From alternative methods to a new toxicology.
    Hartung T
    Eur J Pharm Biopharm; 2011 Apr; 77(3):338-49. PubMed ID: 21195172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An animal protection perspective on 21st century toxicology.
    Stephens ML
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):291-8. PubMed ID: 20574903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental toxicity testing from animal towards embryonic stem cells.
    Pellizzer C; Bremer S; Hartung T
    ALTEX; 2005; 22(2):47-57. PubMed ID: 15953962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimising the design of preliminary toxicity studies for pharmaceutical safety testing in the dog.
    Smith D; Combes R; Depelchin O; Jacobsen SD; Hack R; Luft J; Lammens L; von Landenberg F; Phillips B; Pfister R; Rabemampianina Y; Sparrow S; Stark C; Stephan-Gueldner M
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):95-101. PubMed ID: 15698532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The challenge of reproductive and developmental toxicology under REACH.
    Scialli AR
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):244-50. PubMed ID: 18490093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of alternative methods.
    Goldberg AM
    J Toxicol Sci; 1995 Sep; 20(4):443-9. PubMed ID: 8531238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dawning of a new age of toxicology.
    Leist M; Hartung T; Nicotera P
    ALTEX; 2008; 25(2):103-14. PubMed ID: 18551234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.